Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shannon R McCurdy

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
The Journal of Clinical Investigation|June 1, 2022
Harnessing allogeneic NK cells: improving outcomes with tailored donor lymphocyte infusionShannon R McCurdy
Hematology. American Society of Hematology. Education Program|December 7, 2019
How we perform haploidentical stem cell transplantation with posttransplant cyclophosphamideShannon R McCurdy, Leo Luznik
Blood Reviews|May 17, 2023
Relapse after allogeneic transplantation with post-transplant cyclophosphamide: Shattering myths and evolving insightShannon R McCurdy, Leo Luznik
Bone Marrow Transplantation|August 22, 2019
Post-transplantation cyclophosphamide for chimerism-based toleranceShannon R McCurdy, Leo Luznik
Seminars in Hematology|June 17, 2019
Immune reconstitution after T-cell replete HLA-haploidentical transplantationShannon R McCurdy, Leo Luznik
Blood|November 22, 2019
How we perform haploidentical stem cell transplantation with posttransplant cyclophosphamideShannon R McCurdy, Leo Luznik
Haematologica|July 29, 2021
Dose intensity for induction in acute myeloid leukemia: what, when, and for whom?Shannon R McCurdy, Selina M Luger
Seminars in Hematology|October 30, 2016
Selecting the best haploidentical donorShannon R McCurdy, Ephraim J Fuchs
American Journal of Hematology|February 28, 2024
Age barriers in allogeneic hematopoietic cell transplantation: Raising the silver curtainPashna N Munshi, Shannon R McCurdy
Advances in Hematology|December 30, 2015
Comparable Outcomes for Hematologic Malignancies after HLA-Haploidentical Transplantation with Posttransplantation Cyclophosphamide and HLA-Matched TransplantationShannon R McCurdy, Ephraim J Fuchs
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
The Journal of Clinical Investigation|June 1, 2022
Harnessing allogeneic NK cells: improving outcomes with tailored donor lymphocyte infusionShannon R McCurdy
Hematology. American Society of Hematology. Education Program|December 7, 2019
How we perform haploidentical stem cell transplantation with posttransplant cyclophosphamideShannon R McCurdy, Leo Luznik
Blood Reviews|May 17, 2023
Relapse after allogeneic transplantation with post-transplant cyclophosphamide: Shattering myths and evolving insightShannon R McCurdy, Leo Luznik
Bone Marrow Transplantation|August 22, 2019
Post-transplantation cyclophosphamide for chimerism-based toleranceShannon R McCurdy, Leo Luznik
Seminars in Hematology|June 17, 2019
Immune reconstitution after T-cell replete HLA-haploidentical transplantationShannon R McCurdy, Leo Luznik
Blood|November 22, 2019
How we perform haploidentical stem cell transplantation with posttransplant cyclophosphamideShannon R McCurdy, Leo Luznik
Haematologica|July 29, 2021
Dose intensity for induction in acute myeloid leukemia: what, when, and for whom?Shannon R McCurdy, Selina M Luger
Seminars in Hematology|October 30, 2016
Selecting the best haploidentical donorShannon R McCurdy, Ephraim J Fuchs
American Journal of Hematology|February 28, 2024
Age barriers in allogeneic hematopoietic cell transplantation: Raising the silver curtainPashna N Munshi, Shannon R McCurdy
Advances in Hematology|December 30, 2015
Comparable Outcomes for Hematologic Malignancies after HLA-Haploidentical Transplantation with Posttransplantation Cyclophosphamide and HLA-Matched TransplantationShannon R McCurdy, Ephraim J Fuchs
Pageof 7